Solicitation
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Dept of Defense · Defense Health Agency (DHA) · Sol. HT9427-26-R-E020
Due in 18 days
AI summary Beta
No AI summary for this notice yet.
Save it to generate your own AI brief in its bid workspace: a plain-English summary, the red flags, and how well your business fits.
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Response due
- Oct 23, 2026, 4:00 PM UTC
- Posted
- Sep 24, 2026
- Notice type
- Solicitation
- Solicitation
- HT9427-26-R-E020
- Agency
- Dept of Defense · Defense Health Agency (DHA)
- Office
- Defense Health Agency
- NAICS
- 541715
- Product/service code
- AN13
- Business type
- Engineering, architecture & research
- Place of performance
- Frederick, MD
- Contracting contact
- Bryan Heickmanbryan.g.heickman.civ@health.mil
- Versions
- 2 (amended since first posted)
Full notice text from SAM.gov
This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections. This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product. The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance). The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022.
Similar open opportunities
- STAR-FISH CALL 017 - Secure By DesignThe Air Force Research Laboratory (Space Vehicles Directorate, Kirtland AFB, NM) is asking for white papers under its STAR-FISH research announcement, CALL 017, Secure by Design…
- Synthetic Training Environment (STE) Virtual Software (VSW)The Army (ACC-APG Orlando, for the Simulation program office) is asking industry for solutions to the Synthetic Training Environment Virtual Software, a soldier training…
- Restorative and health-Enhancing Sleep Time (REST)ARPA-H, a federal health research agency, is seeking proposals for its REST program on objective, home-based, closed-loop sleep technologies that detect sleep patterns and…
- Space Environment Technologies and Science (SETS) Broad Agency Announcement (BAA) Call 004The Air Force Research Laboratory (Space Warfare Directorate, Albuquerque, NM) is seeking research proposals under its Space Environment Technologies and Science (SETS) Broad…
- SEEK EAGLE MODELING, ANALYSIS, AND TOOLS SUPPORT (SEMATS) 4The Air Force SEEK EAGLE Office at Eglin AFB, Florida is running a sources sought (market research) notice for a future 5-year services contract called SEMATS 4.